JOSHUA PRICE: Open Payments
NPI 1528714110 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 14 payments from 7 companies in 2025. Trend: 2023 $140 · 2024 $0 · 2025 $443
Food & beverage: $443
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $169 |
| Gilead Sciences, Inc. | 2 | $140 |
| Ardelyx, Inc. | 1 | $54 |
| Madrigal Pharmaceuticals | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| GENZYME CORPORATION | 1 | $16 |
| PFIZER INC. | 1 | $14 |
Products named: SKYRIZI, Livdelzi, IBSRELA, RINVOQ, REZDIFFRA, ENTYVIO, DUPIXENT, VELSIPITY.
Industry payments across ID — which companies pay providers there.
